InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
2
T+90 hit rate
20%
T+90 mean return
-6.9%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by SWARTZ DAVID L, Director. Insider active across 1 company, notably RadNet, Inc.. In total, 17 disclosures have been recorded. Split: 2 buys · 2 sells. Total volume traded: €2.6m. Activity tracked since 2 January 2021. The latest transaction was disclosed on 7 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations17 total
25,000 shares@ US$50.8445.1% of flowCommon StockSEC:0001683168-25-001530:0
2,591 shares0Common StockSEC:0001683168-24-004215:0
20,934 shares@ US$60.4345.0% of flowCommon StockSEC:0001683168-24-004152:0
4,066 shares0Common StockSEC:0001683168-23-004026:0
6,269 shares0Common StockSEC:0001683168-23-004022:0
6,269 shares0Common StockSEC:0001683168-22-005268:0
4,519 shares@ US$33.47454.9% of flowCommon StockSEC:0001683168-21-003580
Ideal exit: 8 May 2022 (T+270)
4,519 shares@ US$33.47450.0031% mcap50.0% of flowCommon StockSEC:0001683168-21-003580:0
Ideal exit: 8 May 2022 (T+270)
3,999 shares0Common StockSEC:0001683168-21-002544
3,999 shares0Common StockSEC:0001683168-21-002544:0
39,382 shares0Common StockSEC:0001683168-21-001821:0
39,382 shares0Common StockSEC:0001683168-21-001821
10,000 sharesCommon StockSEC:0001019687-16-004722:0
5,863 sharesCommon StockSEC:0001019687-16-004722:1
10,297 sharesCommon StockSEC:0001019687-16-004708:0
25,000 sharesCommon StockSEC:0001019687-16-004690:0
11,974 sharesCommon StockSEC:0001019687-16-004690:1
17 of 17 declarations
About SWARTZ DAVID L
David L. Swartz is a Board Member at RadNet, Inc. He plays a key role in the governance of the company, bringing his expertise and experience to the board. RadNet, Inc. is a provider of radiology services, offering innovative and high-quality solutions in the field of medical imaging. Mr. Swartz's commitment to continuous improvement and regulatory compliance supports the company's mission to deliver top-tier healthcare.
